nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP1B1—ovarian cancer	0.316	0.777	CbGaD
Omeprazole—ABCB1—ovarian cancer	0.0908	0.223	CbGaD
Omeprazole—CYP1B1—Paclitaxel—ovarian cancer	0.0497	0.13	CbGbCtD
Omeprazole—ABCG2—Topotecan—ovarian cancer	0.0477	0.125	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—ovarian cancer	0.0359	0.0942	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—ovarian cancer	0.031	0.0812	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—ovarian cancer	0.0268	0.0702	CbGbCtD
Omeprazole—ABCG2—Paclitaxel—ovarian cancer	0.0236	0.0619	CbGbCtD
Omeprazole—ABCG2—Carboplatin—ovarian cancer	0.0222	0.0583	CbGbCtD
Omeprazole—ABCB1—Topotecan—ovarian cancer	0.0172	0.0451	CbGbCtD
Omeprazole—ABCG2—Docetaxel—ovarian cancer	0.0171	0.0448	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—ovarian cancer	0.0127	0.0334	CbGbCtD
Omeprazole—CYP2C8—Paclitaxel—ovarian cancer	0.0126	0.033	CbGbCtD
Omeprazole—ABCB1—Vinorelbine—ovarian cancer	0.0121	0.0318	CbGbCtD
Omeprazole—CYP2D6—Vinorelbine—ovarian cancer	0.0114	0.0299	CbGbCtD
Omeprazole—CYP11A1—corpus luteum—ovarian cancer	0.0113	0.243	CbGeAlD
Omeprazole—CYP3A4—Topotecan—ovarian cancer	0.0103	0.027	CbGbCtD
Omeprazole—CYP11A1—ovarian follicle—ovarian cancer	0.00885	0.19	CbGeAlD
Omeprazole—CYP2C9—Paclitaxel—ovarian cancer	0.00877	0.023	CbGbCtD
Omeprazole—ABCB1—Paclitaxel—ovarian cancer	0.00851	0.0223	CbGbCtD
Omeprazole—CYP3A4—Vinorelbine—ovarian cancer	0.00726	0.019	CbGbCtD
Omeprazole—ABCB1—Docetaxel—ovarian cancer	0.00616	0.0161	CbGbCtD
Omeprazole—CYP3A4—Paclitaxel—ovarian cancer	0.0051	0.0134	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—ovarian cancer	0.00459	0.012	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—ovarian cancer	0.00432	0.0113	CbGbCtD
Omeprazole—CYP3A4—Docetaxel—ovarian cancer	0.00369	0.00967	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—ovarian cancer	0.00275	0.00721	CbGbCtD
Omeprazole—ATP4A—epithelium—ovarian cancer	0.00149	0.032	CbGeAlD
Omeprazole—CYP2C18—uterine cervix—ovarian cancer	0.00121	0.0261	CbGeAlD
Omeprazole—ATP4A—female reproductive system—ovarian cancer	0.00111	0.0238	CbGeAlD
Omeprazole—Lansoprazole—CYP1B1—ovarian cancer	0.00105	0.598	CrCbGaD
Omeprazole—CYP11A1—decidua—ovarian cancer	0.000923	0.0198	CbGeAlD
Omeprazole—ATP4A—testis—ovarian cancer	0.000893	0.0192	CbGeAlD
Omeprazole—CYP2C18—vagina—ovarian cancer	0.000823	0.0177	CbGeAlD
Omeprazole—CYP11A1—gonad—ovarian cancer	0.000812	0.0174	CbGeAlD
Omeprazole—CYP11A1—female reproductive system—ovarian cancer	0.000725	0.0156	CbGeAlD
Omeprazole—ABCC3—decidua—ovarian cancer	0.000716	0.0154	CbGeAlD
Omeprazole—CYP11A1—female gonad—ovarian cancer	0.00066	0.0142	CbGeAlD
Omeprazole—CYP11A1—testis—ovarian cancer	0.000585	0.0126	CbGeAlD
Omeprazole—ABCC3—female reproductive system—ovarian cancer	0.000563	0.0121	CbGeAlD
Omeprazole—ABCG2—myometrium—ovarian cancer	0.000563	0.0121	CbGeAlD
Omeprazole—CYP1B1—decidua—ovarian cancer	0.00056	0.012	CbGeAlD
Omeprazole—ABCC3—female gonad—ovarian cancer	0.000512	0.011	CbGeAlD
Omeprazole—CYP1B1—gonad—ovarian cancer	0.000493	0.0106	CbGeAlD
Omeprazole—CYP1B1—uterus—ovarian cancer	0.00049	0.0105	CbGeAlD
Omeprazole—ABCC3—testis—ovarian cancer	0.000454	0.00976	CbGeAlD
Omeprazole—CYP1B1—female reproductive system—ovarian cancer	0.000441	0.00946	CbGeAlD
Omeprazole—ABCG2—uterine cervix—ovarian cancer	0.000438	0.00941	CbGeAlD
Omeprazole—CYP11A1—lymph node—ovarian cancer	0.000424	0.00911	CbGeAlD
Omeprazole—CYP1A1—epithelium—ovarian cancer	0.000419	0.00901	CbGeAlD
Omeprazole—ABCG2—decidua—ovarian cancer	0.000417	0.00896	CbGeAlD
Omeprazole—CYP1A1—uterine cervix—ovarian cancer	0.000416	0.00893	CbGeAlD
Omeprazole—CYP2C8—endometrium—ovarian cancer	0.000407	0.00875	CbGeAlD
Omeprazole—Pantoprazole—ABCB1—ovarian cancer	0.000402	0.23	CrCbGaD
Omeprazole—CYP1B1—female gonad—ovarian cancer	0.000401	0.00861	CbGeAlD
Omeprazole—ABCG2—endometrium—ovarian cancer	0.000396	0.00851	CbGeAlD
Omeprazole—ABCG2—uterus—ovarian cancer	0.000365	0.00784	CbGeAlD
Omeprazole—CYP1B1—testis—ovarian cancer	0.000356	0.00764	CbGeAlD
Omeprazole—CYP2C19—vagina—ovarian cancer	0.00035	0.00751	CbGeAlD
Omeprazole—CYP1A1—uterus—ovarian cancer	0.000346	0.00744	CbGeAlD
Omeprazole—CYP2C8—female reproductive system—ovarian cancer	0.000337	0.00725	CbGeAlD
Omeprazole—ABCC3—lymph node—ovarian cancer	0.000329	0.00707	CbGeAlD
Omeprazole—CYP1A1—female reproductive system—ovarian cancer	0.000311	0.00669	CbGeAlD
Omeprazole—ABCG2—bone marrow—ovarian cancer	0.00031	0.00665	CbGeAlD
Omeprazole—CYP2C8—vagina—ovarian cancer	0.000305	0.00655	CbGeAlD
Omeprazole—Lansoprazole—ABCB1—ovarian cancer	0.0003	0.172	CrCbGaD
Omeprazole—CYP2C9—female reproductive system—ovarian cancer	0.0003	0.00644	CbGeAlD
Omeprazole—ABCG2—female gonad—ovarian cancer	0.000299	0.00641	CbGeAlD
Omeprazole—ABCG2—vagina—ovarian cancer	0.000297	0.00637	CbGeAlD
Omeprazole—CYP1A1—female gonad—ovarian cancer	0.000283	0.00609	CbGeAlD
Omeprazole—CYP1A1—vagina—ovarian cancer	0.000282	0.00605	CbGeAlD
Omeprazole—ABCB1—myometrium—ovarian cancer	0.000277	0.00596	CbGeAlD
Omeprazole—CYP2C8—testis—ovarian cancer	0.000272	0.00585	CbGeAlD
Omeprazole—ABCB1—embryo—ovarian cancer	0.000267	0.00573	CbGeAlD
Omeprazole—ABCG2—testis—ovarian cancer	0.000265	0.00569	CbGeAlD
Omeprazole—CYP1B1—lymph node—ovarian cancer	0.000258	0.00554	CbGeAlD
Omeprazole—CYP3A4—female reproductive system—ovarian cancer	0.000229	0.00491	CbGeAlD
Omeprazole—CYP2D6—female reproductive system—ovarian cancer	0.000225	0.00483	CbGeAlD
Omeprazole—ABCB1—epithelium—ovarian cancer	0.000218	0.00468	CbGeAlD
Omeprazole—ABCB1—uterine cervix—ovarian cancer	0.000216	0.00464	CbGeAlD
Omeprazole—ABCB1—decidua—ovarian cancer	0.000206	0.00442	CbGeAlD
Omeprazole—CYP2D6—female gonad—ovarian cancer	0.000205	0.0044	CbGeAlD
Omeprazole—ABCB1—endometrium—ovarian cancer	0.000195	0.00419	CbGeAlD
Omeprazole—ABCG2—lymph node—ovarian cancer	0.000192	0.00412	CbGeAlD
Omeprazole—CYP1A1—lymph node—ovarian cancer	0.000182	0.00391	CbGeAlD
Omeprazole—CYP2D6—testis—ovarian cancer	0.000182	0.0039	CbGeAlD
Omeprazole—ABCB1—gonad—ovarian cancer	0.000181	0.00389	CbGeAlD
Omeprazole—ABCB1—uterus—ovarian cancer	0.00018	0.00387	CbGeAlD
Omeprazole—ABCB1—female reproductive system—ovarian cancer	0.000162	0.00347	CbGeAlD
Omeprazole—ABCB1—bone marrow—ovarian cancer	0.000153	0.00328	CbGeAlD
Omeprazole—ABCB1—female gonad—ovarian cancer	0.000147	0.00316	CbGeAlD
Omeprazole—ABCB1—vagina—ovarian cancer	0.000146	0.00314	CbGeAlD
Omeprazole—ABCB1—testis—ovarian cancer	0.000131	0.0028	CbGeAlD
Omeprazole—ABCB1—lymph node—ovarian cancer	9.46e-05	0.00203	CbGeAlD
Omeprazole—Chest pain—Docetaxel—ovarian cancer	6.95e-05	0.000538	CcSEcCtD
Omeprazole—Myalgia—Docetaxel—ovarian cancer	6.95e-05	0.000538	CcSEcCtD
Omeprazole—Arthralgia—Docetaxel—ovarian cancer	6.95e-05	0.000538	CcSEcCtD
Omeprazole—Pancytopenia—Doxorubicin—ovarian cancer	6.94e-05	0.000537	CcSEcCtD
Omeprazole—Nausea—Vinorelbine—ovarian cancer	6.94e-05	0.000537	CcSEcCtD
Omeprazole—Renal failure—Epirubicin—ovarian cancer	6.92e-05	0.000536	CcSEcCtD
Omeprazole—Dyspepsia—Paclitaxel—ovarian cancer	6.92e-05	0.000535	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	6.9e-05	0.000534	CcSEcCtD
Omeprazole—Jaundice—Epirubicin—ovarian cancer	6.87e-05	0.000531	CcSEcCtD
Omeprazole—Stomatitis—Epirubicin—ovarian cancer	6.87e-05	0.000531	CcSEcCtD
Omeprazole—Urinary tract infection—Epirubicin—ovarian cancer	6.85e-05	0.00053	CcSEcCtD
Omeprazole—Conjunctivitis—Epirubicin—ovarian cancer	6.85e-05	0.00053	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—ovarian cancer	6.83e-05	0.000529	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—ovarian cancer	6.83e-05	0.000529	CcSEcCtD
Omeprazole—Decreased appetite—Paclitaxel—ovarian cancer	6.83e-05	0.000529	CcSEcCtD
Omeprazole—Dry mouth—Docetaxel—ovarian cancer	6.79e-05	0.000526	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—ovarian cancer	6.79e-05	0.000526	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	6.78e-05	0.000525	CcSEcCtD
Omeprazole—Fatigue—Paclitaxel—ovarian cancer	6.77e-05	0.000524	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—ovarian cancer	6.75e-05	0.000523	CcSEcCtD
Omeprazole—Constipation—Paclitaxel—ovarian cancer	6.72e-05	0.00052	CcSEcCtD
Omeprazole—Pain—Paclitaxel—ovarian cancer	6.72e-05	0.00052	CcSEcCtD
Omeprazole—Haematuria—Epirubicin—ovarian cancer	6.72e-05	0.00052	CcSEcCtD
Omeprazole—Confusional state—Docetaxel—ovarian cancer	6.71e-05	0.00052	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—ovarian cancer	6.67e-05	0.000516	CcSEcCtD
Omeprazole—Hepatobiliary disease—Epirubicin—ovarian cancer	6.66e-05	0.000516	CcSEcCtD
Omeprazole—Anaphylactic shock—Docetaxel—ovarian cancer	6.66e-05	0.000515	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—ovarian cancer	6.65e-05	0.000515	CcSEcCtD
Omeprazole—Epistaxis—Epirubicin—ovarian cancer	6.64e-05	0.000514	CcSEcCtD
Omeprazole—Infection—Docetaxel—ovarian cancer	6.62e-05	0.000512	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—ovarian cancer	6.61e-05	0.000512	CcSEcCtD
Omeprazole—Sinusitis—Epirubicin—ovarian cancer	6.61e-05	0.000511	CcSEcCtD
Omeprazole—Agranulocytosis—Epirubicin—ovarian cancer	6.57e-05	0.000509	CcSEcCtD
Omeprazole—Shock—Docetaxel—ovarian cancer	6.55e-05	0.000507	CcSEcCtD
Omeprazole—Nervous system disorder—Docetaxel—ovarian cancer	6.53e-05	0.000506	CcSEcCtD
Omeprazole—Thrombocytopenia—Docetaxel—ovarian cancer	6.52e-05	0.000505	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—ovarian cancer	6.52e-05	0.000504	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—ovarian cancer	6.52e-05	0.000504	CcSEcCtD
Omeprazole—Tachycardia—Docetaxel—ovarian cancer	6.5e-05	0.000503	CcSEcCtD
Omeprazole—Feeling abnormal—Paclitaxel—ovarian cancer	6.47e-05	0.000501	CcSEcCtD
Omeprazole—Skin disorder—Docetaxel—ovarian cancer	6.47e-05	0.000501	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	6.46e-05	0.0005	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—ovarian cancer	6.44e-05	0.000498	CcSEcCtD
Omeprazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.42e-05	0.000497	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—ovarian cancer	6.41e-05	0.000496	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—ovarian cancer	6.35e-05	0.000492	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—ovarian cancer	6.35e-05	0.000492	CcSEcCtD
Omeprazole—Anorexia—Docetaxel—ovarian cancer	6.35e-05	0.000491	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—ovarian cancer	6.34e-05	0.000491	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—ovarian cancer	6.33e-05	0.00049	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—ovarian cancer	6.33e-05	0.00049	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—ovarian cancer	6.32e-05	0.000489	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—ovarian cancer	6.29e-05	0.000487	CcSEcCtD
Omeprazole—Pharyngitis—Epirubicin—ovarian cancer	6.28e-05	0.000486	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—ovarian cancer	6.24e-05	0.000483	CcSEcCtD
Omeprazole—Urticaria—Paclitaxel—ovarian cancer	6.24e-05	0.000483	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—ovarian cancer	6.23e-05	0.000482	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—ovarian cancer	6.21e-05	0.000481	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—ovarian cancer	6.21e-05	0.000481	CcSEcCtD
Omeprazole—Body temperature increased—Paclitaxel—ovarian cancer	6.21e-05	0.000481	CcSEcCtD
Omeprazole—Abdominal pain—Paclitaxel—ovarian cancer	6.21e-05	0.000481	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—ovarian cancer	6.2e-05	0.00048	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—ovarian cancer	6.16e-05	0.000477	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—ovarian cancer	6.15e-05	0.000476	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—ovarian cancer	6.11e-05	0.000473	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—ovarian cancer	6.09e-05	0.000472	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—ovarian cancer	6.08e-05	0.000471	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.07e-05	0.00047	CcSEcCtD
Omeprazole—Insomnia—Docetaxel—ovarian cancer	6.02e-05	0.000466	CcSEcCtD
Omeprazole—Paraesthesia—Docetaxel—ovarian cancer	5.98e-05	0.000463	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—ovarian cancer	5.98e-05	0.000463	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—ovarian cancer	5.96e-05	0.000461	CcSEcCtD
Omeprazole—Dyspnoea—Docetaxel—ovarian cancer	5.94e-05	0.00046	CcSEcCtD
Omeprazole—Somnolence—Docetaxel—ovarian cancer	5.92e-05	0.000458	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—ovarian cancer	5.91e-05	0.000457	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—ovarian cancer	5.89e-05	0.000456	CcSEcCtD
Omeprazole—Flushing—Epirubicin—ovarian cancer	5.87e-05	0.000454	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—ovarian cancer	5.86e-05	0.000454	CcSEcCtD
Omeprazole—Dyspepsia—Docetaxel—ovarian cancer	5.86e-05	0.000454	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—ovarian cancer	5.85e-05	0.000453	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—ovarian cancer	5.82e-05	0.000451	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—ovarian cancer	5.81e-05	0.000449	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—ovarian cancer	5.79e-05	0.000448	CcSEcCtD
Omeprazole—Hypersensitivity—Paclitaxel—ovarian cancer	5.79e-05	0.000448	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—ovarian cancer	5.78e-05	0.000447	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—ovarian cancer	5.76e-05	0.000446	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—ovarian cancer	5.75e-05	0.000445	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—ovarian cancer	5.75e-05	0.000445	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—ovarian cancer	5.74e-05	0.000444	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—ovarian cancer	5.73e-05	0.000444	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—ovarian cancer	5.71e-05	0.000442	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—ovarian cancer	5.7e-05	0.000441	CcSEcCtD
Omeprazole—Pain—Docetaxel—ovarian cancer	5.69e-05	0.000441	CcSEcCtD
Omeprazole—Constipation—Docetaxel—ovarian cancer	5.69e-05	0.000441	CcSEcCtD
Omeprazole—Chills—Epirubicin—ovarian cancer	5.67e-05	0.000439	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—ovarian cancer	5.64e-05	0.000436	CcSEcCtD
Omeprazole—Asthenia—Paclitaxel—ovarian cancer	5.64e-05	0.000436	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—ovarian cancer	5.59e-05	0.000432	CcSEcCtD
Omeprazole—Pruritus—Paclitaxel—ovarian cancer	5.56e-05	0.00043	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—ovarian cancer	5.54e-05	0.000429	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—ovarian cancer	5.53e-05	0.000428	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—ovarian cancer	5.5e-05	0.000426	CcSEcCtD
Omeprazole—Feeling abnormal—Docetaxel—ovarian cancer	5.49e-05	0.000425	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—ovarian cancer	5.47e-05	0.000423	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—ovarian cancer	5.45e-05	0.000422	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—ovarian cancer	5.45e-05	0.000422	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—ovarian cancer	5.43e-05	0.00042	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—ovarian cancer	5.42e-05	0.00042	CcSEcCtD
Omeprazole—Tension—Epirubicin—ovarian cancer	5.4e-05	0.000418	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—ovarian cancer	5.39e-05	0.000417	CcSEcCtD
Omeprazole—Diarrhoea—Paclitaxel—ovarian cancer	5.38e-05	0.000416	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—ovarian cancer	5.35e-05	0.000414	CcSEcCtD
Omeprazole—Back pain—Epirubicin—ovarian cancer	5.32e-05	0.000412	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—ovarian cancer	5.29e-05	0.00041	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—ovarian cancer	5.28e-05	0.000409	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—ovarian cancer	5.27e-05	0.000408	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—ovarian cancer	5.26e-05	0.000408	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—ovarian cancer	5.26e-05	0.000408	CcSEcCtD
Omeprazole—Chills—Doxorubicin—ovarian cancer	5.25e-05	0.000406	CcSEcCtD
Omeprazole—Dizziness—Paclitaxel—ovarian cancer	5.2e-05	0.000402	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—ovarian cancer	5.19e-05	0.000402	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—ovarian cancer	5.17e-05	0.0004	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—ovarian cancer	5.13e-05	0.000397	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—ovarian cancer	5.11e-05	0.000395	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—ovarian cancer	5.09e-05	0.000394	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—ovarian cancer	5.09e-05	0.000394	CcSEcCtD
Omeprazole—Agitation—Epirubicin—ovarian cancer	5.06e-05	0.000392	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—ovarian cancer	5.02e-05	0.000388	CcSEcCtD
Omeprazole—Tension—Doxorubicin—ovarian cancer	5e-05	0.000387	CcSEcCtD
Omeprazole—Vomiting—Paclitaxel—ovarian cancer	5e-05	0.000387	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—ovarian cancer	4.99e-05	0.000386	CcSEcCtD
Omeprazole—Malaise—Epirubicin—ovarian cancer	4.96e-05	0.000384	CcSEcCtD
Omeprazole—Rash—Paclitaxel—ovarian cancer	4.95e-05	0.000383	CcSEcCtD
Omeprazole—Dermatitis—Paclitaxel—ovarian cancer	4.95e-05	0.000383	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—ovarian cancer	4.95e-05	0.000383	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—ovarian cancer	4.94e-05	0.000383	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—ovarian cancer	4.93e-05	0.000381	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—ovarian cancer	4.93e-05	0.000381	CcSEcCtD
Omeprazole—Headache—Paclitaxel—ovarian cancer	4.92e-05	0.000381	CcSEcCtD
Omeprazole—Hypersensitivity—Docetaxel—ovarian cancer	4.91e-05	0.00038	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—ovarian cancer	4.9e-05	0.000379	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—ovarian cancer	4.86e-05	0.000376	CcSEcCtD
Omeprazole—Cough—Epirubicin—ovarian cancer	4.8e-05	0.000372	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—ovarian cancer	4.8e-05	0.000372	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—ovarian cancer	4.78e-05	0.00037	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—ovarian cancer	4.75e-05	0.000368	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—ovarian cancer	4.73e-05	0.000366	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—ovarian cancer	4.71e-05	0.000365	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—ovarian cancer	4.71e-05	0.000364	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—ovarian cancer	4.69e-05	0.000363	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—ovarian cancer	4.69e-05	0.000363	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—ovarian cancer	4.69e-05	0.000363	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—ovarian cancer	4.68e-05	0.000362	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—ovarian cancer	4.67e-05	0.000361	CcSEcCtD
Omeprazole—Nausea—Paclitaxel—ovarian cancer	4.67e-05	0.000361	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	4.65e-05	0.00036	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—ovarian cancer	4.63e-05	0.000358	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—ovarian cancer	4.59e-05	0.000355	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—ovarian cancer	4.58e-05	0.000355	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—ovarian cancer	4.58e-05	0.000354	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—ovarian cancer	4.56e-05	0.000353	CcSEcCtD
Omeprazole—Diarrhoea—Docetaxel—ovarian cancer	4.56e-05	0.000353	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—ovarian cancer	4.53e-05	0.000351	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—ovarian cancer	4.5e-05	0.000348	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—ovarian cancer	4.49e-05	0.000348	CcSEcCtD
Omeprazole—Infection—Epirubicin—ovarian cancer	4.46e-05	0.000345	CcSEcCtD
Omeprazole—Cough—Doxorubicin—ovarian cancer	4.44e-05	0.000344	CcSEcCtD
Omeprazole—Shock—Epirubicin—ovarian cancer	4.42e-05	0.000342	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—ovarian cancer	4.41e-05	0.000341	CcSEcCtD
Omeprazole—Dizziness—Docetaxel—ovarian cancer	4.4e-05	0.000341	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—ovarian cancer	4.4e-05	0.00034	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—ovarian cancer	4.4e-05	0.00034	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—ovarian cancer	4.38e-05	0.000339	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—ovarian cancer	4.36e-05	0.000338	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—ovarian cancer	4.34e-05	0.000336	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—ovarian cancer	4.34e-05	0.000336	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—ovarian cancer	4.34e-05	0.000336	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—ovarian cancer	4.34e-05	0.000336	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—ovarian cancer	4.32e-05	0.000334	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.31e-05	0.000333	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—ovarian cancer	4.28e-05	0.000332	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—ovarian cancer	4.28e-05	0.000331	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—ovarian cancer	4.24e-05	0.000328	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—ovarian cancer	4.23e-05	0.000328	CcSEcCtD
Omeprazole—Rash—Docetaxel—ovarian cancer	4.2e-05	0.000325	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—ovarian cancer	4.2e-05	0.000325	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—ovarian cancer	4.19e-05	0.000324	CcSEcCtD
Omeprazole—Headache—Docetaxel—ovarian cancer	4.17e-05	0.000323	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—ovarian cancer	4.16e-05	0.000322	CcSEcCtD
Omeprazole—Infection—Doxorubicin—ovarian cancer	4.13e-05	0.00032	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.09e-05	0.000317	CcSEcCtD
Omeprazole—Shock—Doxorubicin—ovarian cancer	4.09e-05	0.000317	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—ovarian cancer	4.08e-05	0.000316	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—ovarian cancer	4.07e-05	0.000315	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—ovarian cancer	4.06e-05	0.000314	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—ovarian cancer	4.06e-05	0.000314	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—ovarian cancer	4.04e-05	0.000312	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—ovarian cancer	4.03e-05	0.000312	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—ovarian cancer	4.02e-05	0.000311	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—ovarian cancer	4e-05	0.00031	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—ovarian cancer	3.99e-05	0.000309	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—ovarian cancer	3.96e-05	0.000307	CcSEcCtD
Omeprazole—Nausea—Docetaxel—ovarian cancer	3.96e-05	0.000306	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—ovarian cancer	3.95e-05	0.000306	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—ovarian cancer	3.9e-05	0.000302	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—ovarian cancer	3.88e-05	0.0003	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—ovarian cancer	3.87e-05	0.0003	CcSEcCtD
Omeprazole—Pain—Epirubicin—ovarian cancer	3.84e-05	0.000297	CcSEcCtD
Omeprazole—Constipation—Epirubicin—ovarian cancer	3.84e-05	0.000297	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.79e-05	0.000293	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—ovarian cancer	3.76e-05	0.000291	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—ovarian cancer	3.73e-05	0.000289	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—ovarian cancer	3.71e-05	0.000287	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—ovarian cancer	3.7e-05	0.000287	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—ovarian cancer	3.69e-05	0.000286	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—ovarian cancer	3.67e-05	0.000284	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—ovarian cancer	3.66e-05	0.000283	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—ovarian cancer	3.61e-05	0.00028	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.59e-05	0.000278	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—ovarian cancer	3.58e-05	0.000277	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—ovarian cancer	3.57e-05	0.000276	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—ovarian cancer	3.55e-05	0.000275	CcSEcCtD
Omeprazole—Pain—Doxorubicin—ovarian cancer	3.55e-05	0.000275	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—ovarian cancer	3.55e-05	0.000275	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—ovarian cancer	3.55e-05	0.000275	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—ovarian cancer	3.42e-05	0.000265	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.4e-05	0.000263	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—ovarian cancer	3.31e-05	0.000256	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—ovarian cancer	3.3e-05	0.000256	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—ovarian cancer	3.29e-05	0.000254	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—ovarian cancer	3.29e-05	0.000254	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—ovarian cancer	3.22e-05	0.000249	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—ovarian cancer	3.18e-05	0.000246	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—ovarian cancer	3.07e-05	0.000238	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—ovarian cancer	3.06e-05	0.000237	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—ovarian cancer	2.98e-05	0.000231	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—ovarian cancer	2.97e-05	0.00023	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—ovarian cancer	2.94e-05	0.000228	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—ovarian cancer	2.86e-05	0.000221	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—ovarian cancer	2.84e-05	0.00022	CcSEcCtD
Omeprazole—Rash—Epirubicin—ovarian cancer	2.83e-05	0.000219	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—ovarian cancer	2.83e-05	0.000219	CcSEcCtD
Omeprazole—Headache—Epirubicin—ovarian cancer	2.81e-05	0.000218	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—ovarian cancer	2.75e-05	0.000213	CcSEcCtD
Omeprazole—Nausea—Epirubicin—ovarian cancer	2.67e-05	0.000207	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—ovarian cancer	2.64e-05	0.000205	CcSEcCtD
Omeprazole—Rash—Doxorubicin—ovarian cancer	2.62e-05	0.000203	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—ovarian cancer	2.62e-05	0.000203	CcSEcCtD
Omeprazole—Headache—Doxorubicin—ovarian cancer	2.6e-05	0.000202	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—ovarian cancer	2.47e-05	0.000191	CcSEcCtD
Omeprazole—ABCC3—Metabolism—PPP2R1A—ovarian cancer	1.18e-05	0.000348	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.17e-05	0.000346	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYTB—ovarian cancer	1.17e-05	0.000344	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.14e-05	0.000337	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.14e-05	0.000337	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.14e-05	0.000337	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.14e-05	0.000337	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.14e-05	0.000336	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYTB—ovarian cancer	1.14e-05	0.000336	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.14e-05	0.000336	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ABCB1—ovarian cancer	1.13e-05	0.000332	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.12e-05	0.000329	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—FASN—ovarian cancer	1.11e-05	0.000326	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—TYMS—ovarian cancer	1.11e-05	0.000326	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.1e-05	0.000326	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ABCB1—ovarian cancer	1.1e-05	0.000323	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NME2—ovarian cancer	1.09e-05	0.000321	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SLC5A5—ovarian cancer	1.09e-05	0.000321	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.09e-05	0.00032	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—TYMS—ovarian cancer	1.08e-05	0.000317	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.08e-05	0.000317	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYTB—ovarian cancer	1.07e-05	0.000317	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYTB—ovarian cancer	1.06e-05	0.000314	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SLC2A1—ovarian cancer	1.05e-05	0.00031	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.05e-05	0.000309	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.04e-05	0.000307	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CAV1—ovarian cancer	1.03e-05	0.000304	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.03e-05	0.000304	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.02e-05	0.000301	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.02e-05	0.000301	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—FASN—ovarian cancer	1.01e-05	0.000297	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—BRIP1—ovarian cancer	9.96e-06	0.000294	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPP1CC—ovarian cancer	9.96e-06	0.000294	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC5A5—ovarian cancer	9.9e-06	0.000292	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.84e-06	0.00029	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.76e-06	0.000288	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC2A1—ovarian cancer	9.57e-06	0.000282	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	9.47e-06	0.000279	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPP1CC—ovarian cancer	9.38e-06	0.000277	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—BRIP1—ovarian cancer	9.38e-06	0.000277	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CG—ovarian cancer	9.38e-06	0.000277	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—BRIP1—ovarian cancer	9.3e-06	0.000274	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPP1CC—ovarian cancer	9.3e-06	0.000274	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP1B1—ovarian cancer	9.17e-06	0.00027	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYTB—ovarian cancer	9.09e-06	0.000268	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.08e-06	0.000268	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	8.95e-06	0.000264	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPP2R1A—ovarian cancer	8.94e-06	0.000264	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CAV1—ovarian cancer	8.91e-06	0.000263	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.9e-06	0.000262	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.89e-06	0.000262	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	8.71e-06	0.000257	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CAV1—ovarian cancer	8.67e-06	0.000256	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	8.52e-06	0.000251	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	8.52e-06	0.000251	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—YAP1—ovarian cancer	8.36e-06	0.000247	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.33e-06	0.000246	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ABCB1—ovarian cancer	8.3e-06	0.000245	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.28e-06	0.000244	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.27e-06	0.000244	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CD—ovarian cancer	8.25e-06	0.000243	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TYMS—ovarian cancer	8.15e-06	0.00024	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPP2R1A—ovarian cancer	8.13e-06	0.00024	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CG—ovarian cancer	8.12e-06	0.000239	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	8.05e-06	0.000237	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPP1CC—ovarian cancer	7.95e-06	0.000234	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—BRIP1—ovarian cancer	7.95e-06	0.000234	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CG—ovarian cancer	7.9e-06	0.000233	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—YAP1—ovarian cancer	7.67e-06	0.000226	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.59e-06	0.000224	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ABCB1—ovarian cancer	7.55e-06	0.000223	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.43e-06	0.000219	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TYMS—ovarian cancer	7.42e-06	0.000219	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	7.39e-06	0.000218	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.27e-06	0.000215	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CB—ovarian cancer	7.19e-06	0.000212	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	7.15e-06	0.000211	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CD—ovarian cancer	7.14e-06	0.00021	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYTB—ovarian cancer	7.02e-06	0.000207	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CD—ovarian cancer	6.94e-06	0.000205	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—YAP1—ovarian cancer	6.84e-06	0.000202	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—FASN—ovarian cancer	6.82e-06	0.000201	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.78e-06	0.0002	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.77e-06	0.0002	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC5A5—ovarian cancer	6.7e-06	0.000198	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—YAP1—ovarian cancer	6.68e-06	0.000197	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.67e-06	0.000197	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CAV1—ovarian cancer	6.57e-06	0.000194	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC2A1—ovarian cancer	6.48e-06	0.000191	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.34e-06	0.000187	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—YAP1—ovarian cancer	6.29e-06	0.000186	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.28e-06	0.000185	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—FASN—ovarian cancer	6.25e-06	0.000184	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—YAP1—ovarian cancer	6.24e-06	0.000184	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CB—ovarian cancer	6.22e-06	0.000183	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTEN—ovarian cancer	6.21e-06	0.000183	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP1B1—ovarian cancer	6.21e-06	0.000183	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.17e-06	0.000182	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC5A5—ovarian cancer	6.15e-06	0.000181	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPP1CC—ovarian cancer	6.13e-06	0.000181	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BRIP1—ovarian cancer	6.13e-06	0.000181	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CB—ovarian cancer	6.05e-06	0.000178	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.04e-06	0.000178	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CG—ovarian cancer	5.98e-06	0.000176	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CAV1—ovarian cancer	5.98e-06	0.000176	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.95e-06	0.000176	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.94e-06	0.000175	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.81e-06	0.000171	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.79e-06	0.000171	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.69e-06	0.000168	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—FASN—ovarian cancer	5.58e-06	0.000164	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	5.51e-06	0.000162	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5.49e-06	0.000162	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.48e-06	0.000162	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—FASN—ovarian cancer	5.44e-06	0.000161	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CG—ovarian cancer	5.44e-06	0.000161	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.43e-06	0.00016	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTEN—ovarian cancer	5.37e-06	0.000159	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.36e-06	0.000158	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—YAP1—ovarian cancer	5.33e-06	0.000157	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC2A1—ovarian cancer	5.3e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.28e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CD—ovarian cancer	5.26e-06	0.000155	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—ovarian cancer	5.23e-06	0.000154	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.19e-06	0.000153	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.17e-06	0.000153	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—FASN—ovarian cancer	5.13e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCB1—ovarian cancer	5.11e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—FASN—ovarian cancer	5.09e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1B1—ovarian cancer	5.08e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.05e-06	0.000149	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC5A5—ovarian cancer	5.05e-06	0.000149	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.02e-06	0.000148	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TYMS—ovarian cancer	5.02e-06	0.000148	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5e-06	0.000148	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.96e-06	0.000146	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.87e-06	0.000144	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.83e-06	0.000142	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CD—ovarian cancer	4.79e-06	0.000141	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.73e-06	0.00014	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.69e-06	0.000138	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.67e-06	0.000138	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.64e-06	0.000137	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.63e-06	0.000137	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—ovarian cancer	4.6e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CB—ovarian cancer	4.59e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.51e-06	0.000133	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.48e-06	0.000132	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.4e-06	0.00013	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—ovarian cancer	4.38e-06	0.000129	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—FASN—ovarian cancer	4.35e-06	0.000128	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.28e-06	0.000126	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.18e-06	0.000123	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CB—ovarian cancer	4.17e-06	0.000123	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.14e-06	0.000122	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.13e-06	0.000122	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—YAP1—ovarian cancer	4.11e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—ovarian cancer	4.11e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.11e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.09e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAV1—ovarian cancer	4.05e-06	0.000119	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.04e-06	0.000119	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—ovarian cancer	4.01e-06	0.000118	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—ovarian cancer	3.96e-06	0.000117	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.96e-06	0.000117	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.87e-06	0.000114	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.85e-06	0.000113	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.81e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—ovarian cancer	3.79e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—ovarian cancer	3.78e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—ovarian cancer	3.75e-06	0.00011	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAV1—ovarian cancer	3.71e-06	0.000109	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—ovarian cancer	3.69e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—ovarian cancer	3.69e-06	0.000109	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—ovarian cancer	3.6e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—ovarian cancer	3.58e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.54e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.51e-06	0.000104	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.49e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.38e-06	9.96e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—FASN—ovarian cancer	3.35e-06	9.89e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAV1—ovarian cancer	3.31e-06	9.76e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.3e-06	9.73e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.26e-06	9.61e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CD—ovarian cancer	3.24e-06	9.55e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAV1—ovarian cancer	3.23e-06	9.53e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—ovarian cancer	3.2e-06	9.44e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.19e-06	9.4e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.16e-06	9.33e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—ovarian cancer	3.1e-06	9.13e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.05e-06	9.01e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAV1—ovarian cancer	3.05e-06	8.98e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAV1—ovarian cancer	3.02e-06	8.9e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.02e-06	8.89e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—ovarian cancer	3.01e-06	8.89e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.97e-06	8.76e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.94e-06	8.68e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.88e-06	8.51e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CB—ovarian cancer	2.82e-06	8.33e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—ovarian cancer	2.8e-06	8.24e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.77e-06	8.18e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.75e-06	8.11e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.71e-06	7.99e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.65e-06	7.82e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.59e-06	7.63e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.59e-06	7.63e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAV1—ovarian cancer	2.58e-06	7.61e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—ovarian cancer	2.54e-06	7.5e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.52e-06	7.42e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—ovarian cancer	2.47e-06	7.29e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.46e-06	7.27e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—ovarian cancer	2.44e-06	7.2e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.44e-06	7.19e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.42e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.35e-06	6.93e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.31e-06	6.81e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—ovarian cancer	2.28e-06	6.73e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.26e-06	6.65e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—ovarian cancer	2.24e-06	6.6e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.13e-06	6.27e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.11e-06	6.21e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—ovarian cancer	2.08e-06	6.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.07e-06	6.09e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—ovarian cancer	2e-06	5.89e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAV1—ovarian cancer	1.99e-06	5.87e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—ovarian cancer	1.95e-06	5.75e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—ovarian cancer	1.84e-06	5.42e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—ovarian cancer	1.82e-06	5.37e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.81e-06	5.35e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.8e-06	5.31e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.72e-06	5.08e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.59e-06	4.7e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.58e-06	4.65e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—ovarian cancer	1.56e-06	4.59e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.41e-06	4.15e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—ovarian cancer	1.41e-06	4.15e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.39e-06	4.1e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.37e-06	4.05e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.3e-06	3.82e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—ovarian cancer	1.29e-06	3.8e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.28e-06	3.79e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—ovarian cancer	1.2e-06	3.54e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—ovarian cancer	1.15e-06	3.39e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—ovarian cancer	1.12e-06	3.31e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.1e-06	3.24e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—ovarian cancer	1.06e-06	3.12e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—ovarian cancer	1.05e-06	3.09e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—ovarian cancer	8.97e-07	2.64e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.47e-07	2.5e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—ovarian cancer	6.92e-07	2.04e-05	CbGpPWpGaD
